Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of efficacy and safety of glimepiride and sitagliptin
ChiCTR2000033709Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Jul 2020
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of glimepiride and sitagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Primary endpoint: HbA1c. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
glimepiridesitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000033709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033709.